Browse investments

Invest in Zenas BioPharma, Inc. on Stash

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on the development and commercialization of transformative therapies for patients with autoimmune diseases.

To buy fractional shares of Zenas BioPharma, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

ZBIO Performance Breakdown

Share Price

$26.85

Today's change

8.09%

Year to date change (YTD)

null%

Dividend yield

0.0

Last dividend paid

N/A

Last dividend pay date

N/A

About ZBIO

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on the development and commercialization of transformative therapies for patients with autoimmune diseases. The Company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company is developing obexelimab as a potential immunology and inflammation (I&I) franchise for patients in several autoimmune diseases. The first three indications it is pursuing include immunoglobulin G4-related disease (IgG4-RD), relapsing multiple sclerosis (RMS) and systemic lupus erythematosus (SLE). Its other programs include ZB002 (an anti-TNFα monoclonal antibody), ZB004 (a CTLA-4-Ig fusion), and ZB001 and related programs. ZB002 is a recombinant human monoclonal antibody directed at human TNFα.

Zenas BioPharma, Inc. Stock Ticker

ZBIO

For more information

https://zenasbio.com/

The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years. Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by LSEG Data & Analytics in partnership with: LSEG FX in collaboration with: LSEG Risk Intelligence. Stash cannot and does not represent or guarantee that any of the information available via LSEG Data & Analytics is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.

Invest in Zenas BioPharma, Inc. on Stash

Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on the development and commercialization of transformative therapies for patients with autoimmune diseases.

To buy fractional shares of Zenas BioPharma, Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Certain companies are volatile

Certain companies can be volatile, meaning the stock price fluctuates significantly. Don’t put all your eggs into one basket and remember to keep the Stash Way in mind when you invest.

Zenas BioPharma, Inc. stock news

24/7 Wall Street

WisdomTree Launches 2 ETFs on the Texas Stock Exchange, Bringing Hedge Fund-Style Long/Short Strategies to Everyday Investors

Hedge funds have long kept systematic long/short strategies out of reach for ordinary investors, but WisdomTree just listed two ETFs on the Texas Stock Exchange that aim to change that using AI models from a firm WisdomTree now partly owns.

about 24 hours ago

Business Insider

Anthropic commits billions to a 'public benefit fund'

Anthropic said it wants to create a new LLC with the company's stock as its sole asset. The new LLC, a charitable organization, would receive larger stakes as the company grows.

1 day ago

CNBC

Bessent warns Zelenskyy to 'be very careful' about claims U.S. is throttling Starlink

The U.S. Treasury Secretary warned Ukrainian President Volodymyr Zelenskyy to "be very careful" in public statements about U.S. support for Ukraine. U.S.-provided Starlink internet recently slowed in Ukraine, hindering the war-torn country's ability to respond to Russian assaults.

1 day ago

24/7 Wall Street

Ondo's Tokenized Treasury Product Just Passed BlackRock's BUIDL. Is ONDO Undervalued?

Ondo Finance's tokenized Treasury product, the Ondo US Dollar Yield token (USDY), has surpassed BUIDL from BlackRock (NYSE:BLK | BLK Price Prediction) in size. Despite this achievement, the Ondo (CRYPTO:ONDO) token fell 9% during the week ending October 17, 2026.

1 day ago

Why invest with Stash?

Fractional shares

Thousands of stocks and ETFs. No investing minimums.

Unlimited trades

Plus no add-on trading commission fees.^†

Diversification analysis

Custom investment recommendations can help you diversify.

Automatic investing

Dividend reinvestment,⁸ recurring investments, and more.

The Stock-Back® Card

We’ll give you matching stock in companies you shop at.¹

Learn how to invest

Get professional advice and education at every step.

How to buy Zenas BioPharma, Inc. stock on Stash

Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

Zenas BioPharma, Inc.’s share price is determined by its bid-ask spread, which is the difference between the price that buyers are willing to pay and the price that sellers are willing to accept. Zenas BioPharma, Inc.’s price can fluctuate throughout the course of each trading day—when you buy Zenas BioPharma, Inc. through Stash, we execute the market order during our next available trading window (we have two a day). At Stash, we don’t recommend trying to predict the market when buying investments. We believe it can be a better strategy to buy quality investments you believe in, then hang onto them.

Use our historic performance chart to see real-time Zenas BioPharma, Inc. stock price and the Zenas BioPharma, Inc. news feed to help further your research before investing in fractional shares with any dollar amount you choose.

Stash offers one subscription plan: The Stash Plan.

The Stash Plan can help you reach different goals and offers a unique combination of financial accounts and features. This plan includes access to a personal brokerage account—also known as your personal investment account. You can use your Stash personal portfolio to purchase any of the available investments on our platform, as well as access our suite of automatic saving and investing tools. Learn more about Stash pricing.

Once your market order of Zenas BioPharma, Inc. stock is complete, you'll officially be a shareholder of Zenas BioPharma, Inc.!